SAN DIEGO, October 8, 2018 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary Kannaway®, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has released a new line of Sample Packs.
Kannaway® Sample Packs serve as an incredible new tool for sharing the company’s CBD products. Each Sample Pack includes five 50 mg samples and a single travel salve. The samples available in these packs are Kannaway® Pure CBD and Kannaway® Pure Gold.
“We are thrilled to release our new line of easy-to-use Sample Packs,” said Kannaway® Chief Executive Officer Blake Schroeder. “This new product is perfect for those who want to try CBD for the first time, or those who are looking for a portable product to match their active lifestyle.”
According to a report by Brightfield Group, the hemp-derived CBD market will dominate the cannabis industry within four years. The report found that the hemp-derived CBD market is expected to hit $591 million this year alone, with the potential to grow 40 times to $22 billion by 2022.
“We are excited to announce the release of this incredible introductory tool that will allow prospective customers to experience the many benefits of CBD for themselves,” said Medical Marijuana, Inc. Chief Executive Officer Dr. Stuart Titus. “We’re always finding new ways to innovate our product offerings and expand global access to CBD.”
Shop the entire line of Kannaway® Sample Packs in the Kannaway® online store.
###
About Kannaway®
Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visitwww.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSURE
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
CONTACT:
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
1–858-264-6600
